Back
ESC Premium Access

Selective Heart Rate inhibition improves inadequate exercise response in Fontan Circulation

Session: Drug therapy in congenital heart disease - What are the options and the needs?
Topic: Pathophysiology and Mechanisms
Speaker: Doctor B. Ruijsink (London, GB)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Bram Jacobus Bernardus Ruijsink

King's College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

4 more presentations in this session

Thromboembolic prevention in adolescents and adults with Fontan circulation: Is ASS a therapeutical option in long-standing Fontan circulation?

Speaker: Assistant Professor M. Westhoff-Bleck (Hannover, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Thromboembolism and bleeding in adults with congenital heart disease using non-vitamin K antagonist oral anticoagulants for thromboembolic prevention: a prospective worldwide observational study

Speaker: Miss H. Yang (Singapore, SG)

Access
Abstract
Like
Thumbnail

Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension

Speaker: Doctor C. Yan (Beijing, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Drug therapy in adult congenital heart disease: the burden of polypharmacy

Speaker: Ms O. Woudstra (Amsterdam, NL)

Access
Abstract
Like
Thumbnail

Access the full session

Drug therapy in congenital heart disease - What are the options and the needs?

Speakers: Doctor B. Ruijsink, Assistant Professor M. Westhoff-Bleck, Miss H. Yang, Doctor C. Yan, Ms O. Woudstra
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources